Black lung disease market set to hit $22.5B by 2030

The Business Research Company says the global black lung disease market will rise from $10.92 billion in 2025 to $12.51 billion in 2026 and then reach $22.5 billion by 2030. The growth outlook is tied to coal mining activity, broader screening, and more investment in diagnostics and occupational health.

Why it matters: - The black lung disease market is expanding as coal mining continues and more workers are diagnosed earlier. - The growth points to rising demand for screening, diagnostics, treatment, and occupational health programs in mining regions. - The disease remains a serious respiratory threat because coal dust exposure can cause inflammation, scarring, and lasting lung damage.

What happened: - The Business Research Company released its Black Lung Disease Global Market Report 2026, covering market size, trends, and forecasts through 2035. - The report says the market will grow from $10.92 billion in 2025 to $12.51 billion in 2026. - The report projects the market will reach $22.5 billion by 2030. - The report places North America as the largest market in 2025. - The report identifies Asia-Pacific as the fastest-growing region in the coming years. - Download a free sample of the report. - View the full black lung disease market report.

The details: - The report says the market grew at a 14.6% CAGR in the recent period and is forecast to grow at a 15.8% CAGR through 2030. - The report links recent growth to rising coal mining intensity, longer exposure to coal dust, limited early diagnostics in mining areas, more respiratory occupational illnesses, and continued use of traditional diagnostic methods. - Future growth is expected to come from advanced diagnostics, more occupational health spending, stem cell and regenerative medicine research, better healthcare access in mining areas, and stricter worker-safety rules. - Expected market trends include improved imaging for early detection, more preventive screenings, wider use of pulmonary function tests, more regenerative-treatment research, and better coal-dust exposure monitoring. - Black lung disease is a chronic lung condition that primarily affects coal miners and other people exposed to coal dust. - The disease develops when coal dust particles accumulate in the lungs and cause inflammation, scarring, and tissue damage. - The condition can be fatal and can severely reduce quality of life. - Mining activity is a major driver of the market because coal miners inhale harmful dust during extraction work. - In July 2024, the International Energy Agency said global coal production reached a record 8,970 million tonnes in 2023, up 3.1%. - China, India, and Indonesia drove much of that output. - Tuberculosis is another market driver because people with TB can be more vulnerable to black lung disease. - In November 2024, the CDC reported TB cases and incidence rates rose for the third consecutive year in 2023. - Government funding is also supporting the market by backing research, diagnostics, and care programs. - In June 2024, the U.S. Congress said the fiscal year 2025 budget request included $50.174 billion for the NIH and ARPA-H, up $1.363 billion, or 2.8%, from the prior year. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics, and updated graphics and tables.

Between the lines: - The forecast suggests the market is moving from niche occupational health spending toward a broader diagnostic and treatment ecosystem. - Stronger regulation and better access to healthcare could accelerate reported case counts as screening improves, even if underlying exposure levels remain hard to eliminate. - The regional split implies mature health systems will keep leading the market now, while mining-heavy emerging markets could drive the fastest growth next.

What's next: - More mining activity and better diagnostics are likely to keep pushing case detection higher. - Researchers and health systems are expected to focus more on early imaging, pulmonary testing, regenerative therapies, and worker monitoring. - Government funding and occupational safety measures could shape how quickly the market expands in the next several years.